PLAT and androgen insensitivity syndrome: There are currently 2 ongoing clinical trials assessing the safety and efficacy of IV DNase 1 infusion (Dornase Alfa, Pulmozyme, Roche) in AIS patients on top of IV tPA and EVT (EXTEND-IA DNase, NCT05203224 and NETs-target, NCT04785066).